An Exploratory Study on the Efficacy and Safety of Abatacept in the Treatment of Refractory Dermatomyositis
Conditions: Dermatomyositis; Abatacept Intervention: Drug: Abatacept Sponsors: The First Affiliated Hospital with Nanjing Medical University; National Natural Science Foundation of China Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Abatacept | China Health | Dermatology | Dermatomyositis | Hospitals | Orencia | Research | Study